SynMeta
贻如生物
SynMeta (贻如生物) is a synthetic-biology startup founded by Su Rui at the end of 2021 , developing 100% bio-based leather under the brand Mycel. The company uses fermentation to cultivate mycelium—mixing mushroom mycelium with waste fruit, such as the roughly 900 tonnes of cosmetically flawed fruit annually from Dole's Shanghai facility, to produce its material . Linear Capital led SynMeta's angel round in April 2023 and followed on in its Pre-A round in early 2024, with the latter tranche earmarked for building a phased factory in Changzhou and scaling commercial production of artificial leather . Su has described the past year as focused on cutting manufacturing costs across strain development, feedstock selection and fermentation methods to achieve cost parity against conventional materials in most use cases .
AI-generated — may contain errors, please verify.
Coverage
AI4S Doesn't Lack Stories; It Lacks Real Commercial Value | Linear Voice
"Discovery" is often not the hardest part.
线性资本·After the Start of Summer, Growing Without Reserve | Linear Quarterly
Abundant sunshine, lush growth.
线性资本·Spring has arrived — can blossoms be far behind? | Linear Quarterly
Rather than waiting for spring, define it.
线性资本·"YiRu Bio" Partners with ANTA — ANTAZERO Designer Collaboration Now Available Nationwide | Linear Portfolio
First in the world to achieve large-scale production of low-carbon bio-based leather.
线性资本·Linear Voice: 2025 in the Linear Capital Network
Those real and important moments.
线性资本·Linear Capital's Yingzhe Zeng: Early-Stage Investing Isn't a Great Business Model — So Why Do We Keep at It? | Linear View
Knowing full well the path ahead was strewn with thorns, they still ran barefoot alongside the founders.
线性资本·Taking Gems From Fire — Linear Capital's 2024 Year in Review
2024 is coming to a close. I'd like to borrow the theme from our annual meeting in October to summarize this year: *Taking Gems From Fire* — a fitting description of Linear Capital's work this past year.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier tech and innovation fund.
线性资本·Linear Capital's angel-round lead investment project, *SynMetabio*, has raised tens of millions of RMB in a Pre-A round, with existing investor Linear Capital continuing to double down as a follow-on investor.
The cost of bio-based leather manufacturing has dropped sharply, and a commercial inflection point could arrive next year, with tens of millions of yuan in revenue.
线性资本·"贻如生物" Su Rui: How the World's First Continuously Produced 100% Bio-based Leather Was Achieved | Linear Capital Portfolio Interview Series
Today, SynMetabio, a Linear Capital seed-round lead portfolio company, announced it has raised tens of millions of RMB in a Pre-A round. One year after announcing its seed round from Linear Capital in April 2023, SynMetabio has made significant progress, **including optimizing its entire production process, substantially reducing manufacturing costs, and achieving cost advantages for bio-based materials in most application scenarios.** Next, SynMetabio will build a factory in Changzhou to scale up mass production of its synthetic leather.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier technology and innovation fund.
线性资本·Linear Capital's 2023 Retrospective: Moving Forward Through Challenges
In September 2023, [when summarizing Linear Capital's ninth anniversary, we wrote this line: the goal lies far ahead, the road remains difficult, but there is light in our hearts](https://mp.weixin.qq.com/s?__biz=MzAwNTAyMDAyNQ==&mid=2652305248&idx=1&sn=eb922534db0722f5ef06117e
线性资本·Linear Capital Portfolio Company | SynMetabio Signs Exclusive Strategic Partnership with Dole
On November 6, 2023, at the sixth China International Import Expo, Dole and SynMetabio — a Linear Capital portfolio company — formally signed a significant **exclusive strategic partnership agreement**, marking the beginning of their collaboration.
线性资本·Synthetic biology startup **SynBioRay** (贻如生物) has raised tens of millions of RMB in funding, with **Linear Capital** leading the angel round.
Using synthetic biotechnology to cultivate 100% bio-based leather.
线性资本·












